New thinking: Theory vs practice. A case study illustrating evidence-based therapeutic decision making

Colorectal Disease

Volumn 8, Issue SUPPL. 1, 2006, Pages 25-29

  Travis, Simon P L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Evidence based medicine; Individual patient management; Randomized clinical trials; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HYDROCORTISONE; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; METHOTREXATE; PREDNISOLONE;

ABDOMINAL RADIOGRAPHY; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; COCHRANE LIBRARY; COLON RESECTION; COLONOSCOPY; COLORECTAL SURGERY; CONVALESCENCE; DETERIORATION; DIARRHEA; DRUG MEGADOSE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HELMINTH; HOSPITAL DISCHARGE; HUMAN; ILEOSTOMY; INDIVIDUALIZATION; INTERPERSONAL COMMUNICATION; INTESTINE BIOPSY; INTESTINE SURGERY; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCTOCOLECTOMY; SIGMOIDOSCOPY; SYMPTOM; SYSTEMATIC REVIEW; THEORY; TREATMENT OUTCOME; TREATMENT REFUSAL; TRICHURIS; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POUCHES; COLONOSCOPY; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL AGENTS; GLUCOCORTICOIDS; HUMANS; MALE; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 33645464046     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2006.01067.x     Document Type: Article

References (11)

1. Hanauer SB, Sandborn WJ, Kornbluth A, Hardi R, Regalli G, Yeh C. Delayed-release oral mesalamine 4.8 g/day (800mg tablet) versus 2.4 g/ day (400mg tablet) for treatment of moderately active ulcerative colitis: Combined analysis of two randomized, double-blind, controlled trials. Gastroenterology 2005; 128: A74-A75 (Abstract).
2. Lee FI, Jewell DP, Mani V et al. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut 1996; 38: 229-33.
3. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: A meta-analysis. Gut 1997; 40: 775-81.
4. Marteau P, Probert CS, Lindgren S et al. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: A randomised, double blind, placebo controlled study. Gut 2005; 54: 960-5.
5. Järnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89: 1005-13.
6. Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: A long-term experience. Eur J Gastroenterol Hepatol 2005; 17: 79-84.
7. Järnerot G, Hertervig E, Friis-Liby I et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805-11.
8. Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-76.
9. Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 2005; 128: 825-32.
10. Cummings JR, Herrlinger KR, Travis SP, Gorard DA, McIntyre AS, Jewell DP. Oral methotrexate in ulcerative colitis. Aliment Pharmacol Ther 2005; 21: 385-9.
11. Frieri G, Pimpo M, Galletti B et al. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. Dig Liver Dis 2005; 37: 92-6.